Australia is eagerly awaiting the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist that's generating significant buzz in the global weight management landscape. Developed by Novo Nordisk, this https://haleemazdtb169142.wikifordummies.com/9797812/novo_nordisk_s_retatrutide_australia_a_potential_breakthrough_for_weight_management